L-丙氨酰-L-丝氨酰-L-苏氨酰-L-苏氨酰-L-苏氨酰-L-天冬氨酰胺酰-L-酪氨酰-L-苏氨酸

Peptide T is an HIV entry inhibitor discovered in 1986 by researchers at the National Institutes of Health in the United States. Peptide T, and its modified analog Dala1-peptide T-amide (DAPTA), a drug in clinical trials, is a short peptide derived from the HIV envelope protein gp120 which blocks binding and infection of viral strains which use the CCR5 receptor to infect cells.